OneMedNet and Palantir: A Revolutionary Partnership in Healthcare with Artificial Intelligence

OneMedNet Forms Artificial Intelligence Partnership with Palantir

OneMedNet (ONMD), a provider of AI-supported healthcare services, has formed a significant partnership with Palantir Technologies (PLTR). This collaboration aims to enhance the company's artificial intelligence and real-world data analytics operations in the healthcare sector and to capitalize on growth opportunities in this field.

New Opportunities in the AI Healthcare Market

OneMedNet aims to compete in the artificial intelligence healthcare market, expected to reach $868 billion by 2030, by leveraging Palantir's analytics capabilities. Within the framework of this multiyear partnership, Palantir's robust Artificial Intelligence Platform will further strengthen OneMedNet’s data-driven solutions.

Comprehensive Data Access and Analytical Capability

Palantir's platform provides access to over 5 billion administrative requests and 131 million clinical examinations sourced from more than 1,750 healthcare provider sites. This collaboration spans critical treatment areas such as oncology, cardiology, and rare diseases.

Accelerating Innovation

OneMedNet will enhance the AI-focused provider network known as iRWD provided by Palantir’s Artificial Intelligence Platform. This platform aims to accelerate the development of next-generation medical innovations by providing life sciences, medical device, and research organizations with regulatory-grade anonymized clinical data and advanced analytics.

OneMedNet President and CEO Aaron Green stated, “Palantir’s AI platform will revolutionize our ability to deliver reliable and regulation-compliant data at an extraordinary speed. This will enable significant advancements in clinical research and AI-supported healthcare solutions.”

As a result, OneMedNet shares saw a pre-market increase of 46.60%, trading at $1.510 following these positive developments.